Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03504080

Ligand	Ligand name	Chain	PDB	Tanimoto
LUX	(3R,3'R,6'S,9R,9'R,13R,13'S)-4',5'-DIDEHYDRO-5',6',7',8',9,9',10,10',11,11',12,12',13,13',14,14',15,15'-OCTADECAHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C	2BHW	0.71
TES	TESTOSTERONE	A	1JTV	0.72
TES	TESTOSTERONE	A	2Q7L	0.72
TES	TESTOSTERONE	A	2Q7I	0.72
TES	TESTOSTERONE	A,B	1J96	0.72
TES	TESTOSTERONE	A	2Q7K	0.72
TES	TESTOSTERONE	A,B	1Q13	0.72
TES	TESTOSTERONE	H	1I9J	0.72
TES	TESTOSTERONE	A,B	1AFS	0.72
TES	TESTOSTERONE	H	1VPO	0.72
TES	TESTOSTERONE	A	2Q7J	0.72
TES	TESTOSTERONE	A,B	3BUR	0.72
TES	TESTOSTERONE	A	2AM9	0.72
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.75
B2S	(3alpha,7alpha)-3,7,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one	A	3B2S	0.71
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.71
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.71
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.71
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.78
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.7
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.7
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.7
803	LOVASTATIN	A,B	1CQP	0.8
0MA	maslinic acid	A	2QN2	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.75
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.75
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.75
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.75
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.75
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.72
HEQ	3-[18-(4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-1-ENYL)-3,7,12,16-TETRAMETHYL-OCTADECA-1,3,5,7,9,11,13,15, 17-NONAENYL]-2,4,4-TRIMETHYL-CYCLOHEX-2-ENONE	A,B	1M98	0.71
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.74
114	COMPACTIN	A,B,C,D	1HW8	0.76
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.76
RGC	REIDISPONGIOLIDE C	A	2ASP	0.71
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.75
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.81
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.71
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.71